Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

Cellular therapy of Epstein-Barr virus (EBV)(+) posttransplantation lymphoproliferative diseases (PTLD) in cord blood transplant (CBT) recipients is limited by lack of donor access and the donor's naive neonatal immune system. We therefore used partially human leukocyte antigen–matched third-pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Barker, Juliet N., Doubrovina, Ekaterina, Sauter, Craig, Jaroscak, Jennifer J., Perales, Miguel A., Doubrovin, Mikhail, Prockop, Susan E., Koehne, Guenther, O'Reilly, Richard J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2010
Soggetti:
Transplantation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012598/
https://ncbi.nlm.nih.gov/pubmed/20826724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-04-281873
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi